AUREALIS OY
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Holding
- Established
- 2010-04-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
5
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:4
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Phase 2
1 (20.0%)Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)
Phase 2
Recruiting
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Aurealis Oy
- Target Recruit Count
- 60
- Registration Number
- NCT06111183
- Locations
- 🇩🇪
Institut für Diabetesforschung Muenster GmbH, Münster, Germany
🇩🇪Hauärztliche und Diabetologische Praxis, Pirna, Germany
🇮🇹Ospedale San Donato, Arezzo, Italy
Treatment of Diabetic Foot Ulcers With AUP1602-C
Phase 1
Completed
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Aurealis Oy
- Target Recruit Count
- 26
- Registration Number
- NCT04281992
- Locations
- 🇩🇪
Medizinische Hochschule Hannover (MHH) CRC Core Facility, Hannover, Germany
🇵🇱Mikomed, Łódź, Poland
News
No news found